Shuai Song

1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Loss of eIF3m aggravates myocardial ischemia/reperfusion injury via enhancing nitrative damage and inhibiting glycolytic reprogramming.

Loss of eIF3m aggravates myocardial ischemia/reperfusion injury via enhancing nitrative damage and inhibiting glycolytic reprogramming.

Journal: Science bulletin

Published: January 10, 2026

Extension Catheter-Assisted Balloon Anchoring Technique for Retrieval of an Entrapped Balloon Catheter During PCI.

Extension Catheter-Assisted Balloon Anchoring Technique for Retrieval of an Entrapped Balloon Catheter During PCI.

Journal: JACC. Case reports

Published: September 22, 2025

FOXM1 Protects Against Myocardial Ischemia-Reperfusion Injury in Rodent and Porcine Models by Suppressing MKRN1-Dependent LKB1 Ubiquitination.

FOXM1 Protects Against Myocardial Ischemia-Reperfusion Injury in Rodent and Porcine Models by Suppressing MKRN1-Dependent LKB1 Ubiquitination.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 13, 2025

Z-DNA-binding protein 1 exacerbates myocardial ischemia‒reperfusion injury by inducing noncanonical cardiomyocyte PANoptosis.

Z-DNA-binding protein 1 exacerbates myocardial ischemia‒reperfusion injury by inducing noncanonical cardiomyocyte PANoptosis.

Journal: Signal transduction and targeted therapy

Published: February 25, 2025

Enhancing panvascular medicine: unveiling the nexus of pan-cardio-oncology and expanding therapeutic frontiers.

Enhancing panvascular medicine: unveiling the nexus of pan-cardio-oncology and expanding therapeutic frontiers.

Journal: Science bulletin

Published: January 19, 2025

GLP-1R agonists and heart failure: novel beneficial effects suggested by Mendelian randomization.

GLP-1R agonists and heart failure: novel beneficial effects suggested by Mendelian randomization.

Journal: European heart journal

Published: October 15, 2024

Retraction notice to Corrigendum to "Amphiregulin promotes cardiac fibrosis post myocardial infarction by inducing the endothelial-mesenchymal transition via the EGFR pathway in endothelial cells" [Exp. Cell Res. Volume 429, Issue 2, 15 August 2023, 113673].

Retraction notice to Corrigendum to "Amphiregulin promotes cardiac fibrosis post myocardial infarction by inducing the endothelial-mesenchymal transition via the EGFR pathway in endothelial cells" [Exp. Cell Res. Volume 429, Issue 2, 15 August 2023, 113673].

Journal: Experimental cell research

Published: August 14, 2024

Cardiac fibroblast Foxm1 deficiency prevents pressure overload-induced cardiac remodeling via the Usp10/MKK6-p38γ MAPK axis.

Cardiac fibroblast Foxm1 deficiency prevents pressure overload-induced cardiac remodeling via the Usp10/MKK6-p38γ MAPK axis.

Journal: Cell death and differentiation

Published: August 07, 2024

Ubiquitin proteasome system in cardiac fibrosis.

Ubiquitin proteasome system in cardiac fibrosis.

Journal: Journal of advanced research

Published: July 10, 2024

BRD4 as a therapeutic target for atrial fibrosis and atrial fibrillation.

BRD4 as a therapeutic target for atrial fibrosis and atrial fibrillation.

Journal: European journal of pharmacology

Published: November 22, 2023

Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction.

Downregulation of apoptotic repressor AVEN exacerbates cardiac injury after myocardial infarction.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 10, 2023

A novel intracoronary hypothermia device reduces myocardial reperfusion injury in pigs.

A novel intracoronary hypothermia device reduces myocardial reperfusion injury in pigs.

Journal: Chinese medical journal

Published: September 19, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026